PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Financial Enhancement Group LLC's Holding History (CIK: 0001641438)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 41,818 Value ($000) $1,062 Avg Close $40.40 Range $32.50 - $48.00

Q1 2023

Shares 41,818 Value ($000) $1,062 Avg Close $16.79 Range $10.62 - $25.69

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	41,818	$1,062	$40.40	$32.50 - $48.00
Q1 2023	41,818	$1,062	$16.79	$10.62 - $25.69